Azenta, Inc. AZTA 深滬

已收盤 04-02 16:00:00 美东时间

22.63

+1.450

+6.85%

華盛通

立即下載

最高22.665
今開20.78
成交量 111.14万股
最低 20.39
昨收 21.18
總市值 10.42亿
52周最高 41.73
市盈率 ^靜 --
換手率 2.41%
52周最低 19.87
委比 44.11%
總股本 4606.15万
歷史最高 124.69
量比 1.31
振幅 10.74%
歷史最低 3.92
每手 1
風險率 4.33%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Axe Compute (NASDAQ:AGPU) shares increased by 23.0% to $4.38 during We...

04-02 05:05
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价

今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元

03-18 10:48
Needham Reiterates Buy on Azenta, Maintains $44 Price Target

Needham analyst David Saxon reiterates Azenta (NASDAQ:AZTA) with a Buy and maintains $44 price target.

03-17 18:50
Azenta Subsidiary Azenta UK Acquires UK Biocentre Limited For £20.5 Million

The total consideration was GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon the completion of certain milestones.

03-04 22:13
Azenta Collaborates With Frontier Space To Carry Out Scientific Experiments In Space

Azenta, Inc. (NASDAQ:AZTA) today announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge scientific experiments in space. This collaboration

02-10 05:09
美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价

今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元

02-06 16:52
财报速睇 | Azenta, Inc. 2025财年Q4营收1.49亿美元，同比增长1.4%；归母净利润亏损0.15亿美元，同比亏损扩大36.4%

华盛资讯2月6日讯，Azenta, Inc.公布2025财年Q4业绩，公司Q4营收1.49亿美元，同比增长1.4%，归母净利润亏损0.15亿美元，同比亏损扩大36.4%。

02-06 14:36
财报速睇 | Azenta, Inc. 2025财年Q4营收1.49亿美元，同比增长0.8%；归母净利润亏损0.15亿美元，同比亏损扩大40.4%

华盛资讯2月5日讯，Azenta, Inc.公布2025财年Q4业绩，公司Q4营收1.49亿美元，同比增长0.8%，归母净利润亏损0.15亿美元，同比亏损扩大40.4%。

02-05 13:19
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价

今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元

02-05 11:28
Azenta shares are trading lower after the company reported worse-than-expected Q1 EPS results.

Azenta shares are trading lower after the company reported worse-than-expected ...

02-05 02:10

派息除權日	每股總股息	派息日期
2021-12-02	0.10	2021-12-23
2021-09-02	0.10	2021-09-24
2021-06-03	0.10	2021-06-25
2021-03-04	0.10	2021-03-26
2020-12-03	0.10	2020-12-17
2020-09-03	0.10	2020-09-25
2020-06-04	0.10	2020-06-26
2020-03-05	0.10	2020-03-27
2019-12-05	0.10	2019-12-20
2019-09-05	0.10	2019-09-27
2019-06-06	0.10	2019-06-28
2019-02-28	0.10	2019-03-22
2018-12-06	0.10	2018-12-20
2018-09-06	0.10	2018-09-28
2018-05-31	0.10	2018-06-22
2018-03-01	0.10	2018-03-23
2017-11-30	0.10	2017-12-22
2017-09-07	0.10	2017-09-29
2017-05-31	0.10	2017-06-23
2017-03-01	0.10	2017-03-24
2016-11-30	0.10	2016-12-23
2016-08-31	0.10	2016-09-23
2016-06-01	0.10	2016-06-24
2016-03-02	0.10	2016-03-24
2015-12-02	0.10	2015-12-22
2015-09-02	0.10	2015-09-25
2015-06-03	0.10	2015-06-26
2015-03-04	0.10	2015-03-27
2014-12-03	0.10	2014-12-26
2014-09-03	0.10	2014-09-26
2014-06-04	0.08	2014-06-27
2014-03-05	0.08	2014-03-28
2013-12-04	0.08	2013-12-27
2013-09-04	0.08	2013-09-27
2013-06-05	0.08	2013-06-28
2013-03-06	0.08	2013-03-29
2012-12-05	0.08	2012-12-28
2012-09-05	0.08	2012-09-28
2012-06-06	0.08	2012-06-29
2012-03-07	0.08	2012-03-30
2011-12-07	0.08	2011-12-30
2011-09-07	0.08	2011-09-30

公司名稱	Azenta, Inc.
行業分類	Medical/Nursing Services
業務描述	Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Azenta, Inc. AZTA 深 滬

22.63

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Azenta, Inc. AZTA 深滬